Essays about: "sweden pharmaceutical companies"
Showing result 1 - 5 of 25 essays containing the words sweden pharmaceutical companies.
-
1. Complex KPIs versus the usual benchmarks : a case study on Svensk Dos order picking department
University essay from SLU/Dept. of EconomicsAbstract : This thesis addresses the research gap of a limited discussion on how to establish targets and expectations for Key Performance Indicators (KPIs) related to order processing in warehouse settings. It emphasizes the scarcity of studies addressing this problem and the challenges faced by larger companies in monitoring their order processing performance without clear benchmarks. READ MORE
-
2. Managing operations resources and processes for competitive advantage : A study on the performance of Swedish pharmaceutical companies during the COVID-19 pandemic
University essay from Blekinge Tekniska Högskola/Institutionen för industriell ekonomiAbstract : The outbreak of coronavirus disease 2019 (COVID-19) has caused immense challenges to businesses and people’s lives. For the pharmaceutical industry, these challenges entail changes in demand, supply chain, consumption trends, as well as a shift towards telemedicine and changes in R&D priorities. READ MORE
-
3. Pharmaceutical Project Risk Identification : A Qualitative Study of Swedish Companies' Pharmaceutical Project Risk Identification Process
University essay from Umeå universitet/FöretagsekonomiAbstract : The pharmaceutical industry has received increasing attention from society in recent years, mainly due to the development of vaccines to counteract the spread of Covid-19. While other industries have received sympathy for delays, inconveniences, and difficulties the pressure towards the pharmaceutical industry to produce the vaccine against the virus has increased. READ MORE
-
4. Risk Communication of New Drugs : A qualitative interview study
University essay from Uppsala universitet/Institutionen för farmaciAbstract : Background: Pharmaceutical development has taken new ground in recent decades and placed new demands on the regulations. Since 2005, a risk management plan (RMP) has been required when applying for a first marketing authorization for a drug. The RMP forms the basis for how identified risks with the drug are to be managed. READ MORE
-
5. Adoption of Additive Manufacturing in the Medical Industry within Sweden : Stakeholder analysis in the process of adoption of AM in the medical industry and their influence on each other
University essay from Uppsala universitet/Institutionen för samhällsbyggnad och industriell teknikAbstract : Additive manufacturing (AM) is a printing technology which can produce 3-dimensional solid object by adding layers of material from 3D model data. AM has numerous benefits and can bring a new industrial revolution. To have a smooth transition in the technology, organizations must consider involved stakeholders’ interests. READ MORE